Publication Information

{'id': 'https://openalex.org/W2145963631', 'doi': 'https://doi.org/10.1177/107424849800300109', 'title': 'The Effect of Atorvastatin on the Human Lens After 52 Weeks of Treatment', 'display_name': 'The Effect of Atorvastatin on the Human Lens After 52 Weeks of Treatment', 'publication_year': 1998, 'publication_date': '1998-03-01', 'ids': {'openalex': 'https://openalex.org/W2145963631', 'doi': 'https://doi.org/10.1177/107424849800300109', 'mag': '2145963631', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/10684483'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1177/107424849800300109', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S130832228', 'display_name': 'Journal of Cardiovascular Pharmacology and Therapeutics', 'issn_l': '1074-2484', 'issn': ['1074-2484', '1940-4034'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320017', 'host_organization_name': 'SAGE Publishing', 'host_organization_lineage': ['https://openalex.org/P4310320017'], 'host_organization_lineage_names': ['SAGE Publishing'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5084950888', 'display_name': 'Leon Reid', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210123418', 'display_name': 'Cincinnati Eye Institute', 'ror': 'https://ror.org/02zhwmh74', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210123418']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Leon Reid', 'raw_affiliation_strings': ['Eye Physicians of Cincinnati, Cincinnati, Ohio'], 'affiliations': [{'raw_affiliation_string': 'Eye Physicians of Cincinnati, Cincinnati, Ohio', 'institution_ids': ['https://openalex.org/I4210123418']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5032536488', 'display_name': 'Rebecca Bakker‐Arkema', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Rebecca Bakker-Arkema', 'raw_affiliation_strings': ['Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co., Ann Arbor, Michigan'], 'affiliations': [{'raw_affiliation_string': 'Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co., Ann Arbor, Michigan', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5036984625', 'display_name': 'Donald M. Black', 'orcid': 'https://orcid.org/0000-0003-2740-2141'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Donald Black', 'raw_affiliation_strings': ['Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co., Ann Arbor, Michigan'], 'affiliations': [{'raw_affiliation_string': 'Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co., Ann Arbor, Michigan', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 2000, 'currency': 'USD', 'value_usd': 2000, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 6, 'citation_normalized_percentile': {'value': 0.677235, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 73, 'max': 75}, 'biblio': {'volume': '3', 'issue': '1', 'first_page': '71', 'last_page': '76'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11553', 'display_name': 'Acne and Rosacea Treatments and Effects', 'score': 0.9885, 'subfield': {'id': 'https://openalex.org/subfields/2708', 'display_name': 'Dermatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11553', 'display_name': 'Acne and Rosacea Treatments and Effects', 'score': 0.9885, 'subfield': {'id': 'https://openalex.org/subfields/2708', 'display_name': 'Dermatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10170', 'display_name': 'Retinal Diseases and Treatments', 'score': 0.9465, 'subfield': {'id': 'https://openalex.org/subfields/2731', 'display_name': 'Ophthalmology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10394', 'display_name': 'Lipoproteins and Cardiovascular Health', 'score': 0.9435, 'subfield': {'id': 'https://openalex.org/subfields/2746', 'display_name': 'Surgery'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/lovastatin', 'display_name': 'Lovastatin', 'score': 0.9751046}], 'concepts': [{'id': 'https://openalex.org/C2780940807', 'wikidata': 'https://www.wikidata.org/wiki/Q417740', 'display_name': 'Lovastatin', 'level': 3, 'score': 0.9751046}, {'id': 'https://openalex.org/C2777482532', 'wikidata': 'https://www.wikidata.org/wiki/Q668093', 'display_name': 'Atorvastatin', 'level': 2, 'score': 0.9715704}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.94522023}, {'id': 'https://openalex.org/C2778257484', 'wikidata': 'https://www.wikidata.org/wiki/Q555066', 'display_name': 'Visual acuity', 'level': 2, 'score': 0.5852095}, {'id': 'https://openalex.org/C118487528', 'wikidata': 'https://www.wikidata.org/wiki/Q161437', 'display_name': 'Ophthalmology', 'level': 1, 'score': 0.5037591}, {'id': 'https://openalex.org/C2778163477', 'wikidata': 'https://www.wikidata.org/wiki/Q43656', 'display_name': 'Cholesterol', 'level': 2, 'score': 0.46277913}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3982396}, {'id': 'https://openalex.org/C141071460', 'wikidata': 'https://www.wikidata.org/wiki/Q40821', 'display_name': 'Surgery', 'level': 1, 'score': 0.32066882}], 'mesh': [], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1177/107424849800300109', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S130832228', 'display_name': 'Journal of Cardiovascular Pharmacology and Therapeutics', 'issn_l': '1074-2484', 'issn': ['1074-2484', '1940-4034'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320017', 'host_organization_name': 'SAGE Publishing', 'host_organization_lineage': ['https://openalex.org/P4310320017'], 'host_organization_lineage_names': ['SAGE Publishing'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/10684483', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.79}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 15, 'referenced_works': ['https://openalex.org/W1941540018', 'https://openalex.org/W2044132381', 'https://openalex.org/W2046524469', 'https://openalex.org/W2051349291', 'https://openalex.org/W2089680404', 'https://openalex.org/W2095126661', 'https://openalex.org/W2104918389', 'https://openalex.org/W2106536809', 'https://openalex.org/W2118310760', 'https://openalex.org/W2123420731', 'https://openalex.org/W2135025359', 'https://openalex.org/W2169935588', 'https://openalex.org/W2181807372', 'https://openalex.org/W2460374577', 'https://openalex.org/W4243078951'], 'related_works': ['https://openalex.org/W4230939803', 'https://openalex.org/W3024196814', 'https://openalex.org/W2613139589', 'https://openalex.org/W2369111324', 'https://openalex.org/W2349170458', 'https://openalex.org/W2347388571', 'https://openalex.org/W2206535468', 'https://openalex.org/W2145963631', 'https://openalex.org/W2017997482', 'https://openalex.org/W1987049947'], 'abstract_inverted_index': {'Background:': [0], 'The': [1], 'effect': [2], 'of': [3, 15, 24, 29, 171, 219, 255, 270], 'atorvastatin': [4, 123, 190, 226], 'calcium': [5], '(Lipitor,': [6], 'Parke-Davis,': [7], 'Morris': [8], 'Plains,': [9], 'NJ)': [10], 'on': [11], 'the': [12, 108, 117, 169, 189, 196, 217, 267], 'crystalline': [13], 'lenses': [14], 'hypercholesterolemic': [16], 'patients': [17, 46, 145, 223], 'was': [18, 59, 104, 114, 204, 248], 'evaluated': [19, 60, 96], 'and': [20, 36, 42, 100, 174, 179, 183, 191, 227, 247], 'compared': [21, 259], 'with': [22, 122, 138, 225, 230, 234, 251, 260], 'that': [23, 52], 'lovastatin': [25, 139, 192], 'after': [26], '52': [27, 92], 'weeks': [28], 'treatment': [30], 'to': [31, 106], 'reduce': [32], 'cholesterol': [33, 134], 'levels.': [34], 'Methods': [35], 'Results:': [37], 'Six': [38], 'hundred': [39], 'ninety-six': [40], 'atorvastatin-treated': [41], '235': [43], 'lovastatin-': [44], 'treated': [45, 121, 137, 224, 229], 'completed': [47], 'a': [48, 101, 262], 'large': [49], 'safety': [50], 'study': [51], 'included': [53], 'an': [54, 252], 'ophthalmologic': [55], 'examina': [56], 'tion.': [57], 'Efficacy': [58], 'as': [61], 'mean': [62], 'percent': [63, 197], 'change': [64], 'from': [65], 'baseline': [66], 'in': [67, 132, 146, 168, 199, 206, 216, 266], 'low-density': [68], 'lipopro': [69], 'tein': [70], '(LDL)': [71], 'cholesterol.': [72], 'Patients': [73, 94, 120], 'received': [74], 'atorvastatin,': [75, 235], '10': [76, 236], 'or': [77, 80, 83, 91, 237], '20': [78, 82, 238], 'mg,': [79, 85, 239], 'lovastatin,': [81, 261], '40': [84], 'once': [86], 'daily': [87], 'for': [88], 'either': [89], '36': [90], 'weeks.': [93], 'were': [95, 154, 160, 211], 'by': [97], 'slit-lamp': [98], 'examination,': [99], 'standardized': [102], 'format': [103], 'used': [105], 'describe': [107], 'findings.': [109], 'Best': [110], 'corrected': [111, 201], 'visual': [112, 202], 'acuity': [113, 203], 'measured': [115], 'using': [116], 'Snellen': [118], 'chart.': [119], 'had': [124], 'significantly': [125, 240], '(': [126, 163, 243], 'P': [127, 164, 244], '≤': [128, 165], '.05)': [129, 166, 246], 'greater': [130], 'decreases': [131], 'LDL': [133], 'than': [135], 'those': [136, 228], '(37%': [140], 'vs': [141], '29%).': [142], 'Although': [143], 'some': [144], 'both': [147, 207], 'groups': [148], 'experienced': [149], 'various': [150], 'lenticular': [151, 220, 256], 'opacities,': [152], 'none': [153], 'considered': [155], 'unexpected.': [156], 'In': [157, 194], 'addition,': [158], 'there': [159, 210], 'no': [161, 212], 'significant': [162, 214], 'differences': [167, 215], 'distribution': [170], 'cortical': [172], 'opacities': [173], 'spokes': [175], 'right': [176], 'eye': [177, 181], '(OD)': [178], 'left': [180], '(OS)': [182, 187], 'posterior': [184], 'subcapsular': [185], 'opacity': [186, 221, 257], 'between': [188, 222], 'groups.': [193, 208], 'general,': [195], 'deterioration': [198], 'best': [200], 'similar': [205], 'Overall,': [209], 'clinically': [213], 'development': [218, 258], 'lovastatin.': [231], 'Conclusions:': [232], 'Treatment': [233], 'reduced': [241], 'LDL-cholesterol': [242], '<': [245], 'not': [249], 'associated': [250], 'increased': [253], 'risk': [254], 'widely': [263], 'prescribed': [264], 'compound': [265], 'same': [268], 'class': [269], 'drugs.': [271]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2145963631', 'counts_by_year': [{'year': 2022, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 1}], 'updated_date': '2024-12-13T11:32:06.868816', 'created_date': '2016-06-24'}